A detailed history of Mcf Advisors LLC transactions in Artivion, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 423 shares of AORT stock, worth $11,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares
423
Previous 172 145.93%
Holding current value
$11,958
Previous $4,000 175.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$24.33 - $28.46 $6,106 - $7,143
251 Added 145.93%
423 $11,000
Q2 2024

Aug 05, 2024

BUY
$19.62 - $25.65 $3,374 - $4,411
172 New
172 $4,000
Q3 2022

Nov 09, 2022

BUY
$13.31 - $23.25 $2,422 - $4,231
182 New
182 $3,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.14B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.